About BRC Therapeutics
BRC Therapeutics is a company based in Monterey (United States) founded in 2017. It operates as a HealthTech. BRC Therapeutics has raised $25.26 million across 4 funding rounds from investors including Argonautic, Intrinsic Capital Partners and Achari Ventures. The company has 16 employees as of December 31, 2024. BRC Therapeutics offers products and services including CRPS Therapeutic Candidate and AIIA Therapeutic Candidate.
- Headquarter Monterey, United States
- Employees 16 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biopharmaceutical Research Company
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25.26 M (USD)
in 4 rounds
-
Latest Funding Round
$676.07 K (USD), Series A
Aug 09, 2023
-
Investors
Argonautic
& 5 more
-
Employee Count
16
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BRC Therapeutics
BRC Therapeutics offers a comprehensive portfolio of products and services, including CRPS Therapeutic Candidate and AIIA Therapeutic Candidate. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapeutic candidate tested for Complex Regional Pain Syndrome.
Therapeutic candidate tested for Aromatase Inhibitor-Induced Arthralgia.
Unlock access to complete
Funding Insights of BRC Therapeutics
BRC Therapeutics has successfully raised a total of $25.26M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $676.07 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $676,065
-
First Round
First Round
(02 Oct 2020)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Series A - BRC Therapeutics | Valuation |
investors |
|
| Jul, 2022 | Amount | Series A - BRC Therapeutics | Valuation | Intrinsic Capital Partners | |
| Mar, 2022 | Amount | Seed - BRC Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BRC Therapeutics
BRC Therapeutics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Argonautic, Intrinsic Capital Partners and Achari Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Intrinsic Capital Partners.
|
Founded Year | Domain | Location | |
|
Achari Ventures is engaged in investment across niche industries.
|
Founded Year | Domain | Location | |
|
Growth equity investments are made in hyper-growth markets by AFI Capital Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BRC Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BRC Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Brc Therapeutics Comparisons
Competitors of BRC Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BRC Therapeutics
When was BRC Therapeutics founded?
BRC Therapeutics was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is BRC Therapeutics located?
BRC Therapeutics is headquartered in Monterey, United States. It is registered at Monterey, California, United States.
Is BRC Therapeutics a funded company?
BRC Therapeutics is a funded company, having raised a total of $25.26M across 4 funding rounds to date. The company's 1st funding round was a Seed of $2.54M, raised on Oct 02, 2020.
How many employees does BRC Therapeutics have?
As of Dec 31, 2024, the latest employee count at BRC Therapeutics is 16.
What does BRC Therapeutics do?
BRC Therapeutics is engaged in the development of innovative therapeutics aimed at providing relief from pain and other symptoms in acute and chronic conditions. The company has established a pipeline of prescription medicines based on cannabinoids, targeting pain, neurological, and inflammatory conditions. Two investigational products are currently under clinical trials for Complex Regional Pain Syndrome (CRPS) and Aromatase Inhibitor-Induced Arthralgia (AIIA). The organization is committed to creating multimodal therapeutics designed for safety and efficacy, ensuring patient comfort. BRC operates as a fully integrated entity, driving innovation from development through to commercialization within the regulated cannabinoid therapeutics sector.
What products or services does BRC Therapeutics offer?
BRC Therapeutics offers CRPS Therapeutic Candidate and AIIA Therapeutic Candidate.
Who are BRC Therapeutics's investors?
BRC Therapeutics has 6 investors. Key investors include Argonautic, Intrinsic Capital Partners, Achari Ventures, AFI Capital Partners, and Delta Emerald Ventures.